https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-capivasertib-for-triple-negative-breast-cancer-capitello-290
A trial of capivasertib for triple negative breast cancer (CAPItello 290)
This trial is for people with triple negative breast cancer that has come back or spread to another part of the body.
triple negative breast cancertrialcapivasertib
https://en.wikipedia.org/wiki/Capivasertib
Capivasertib - Wikipedia
capivasertibwikipedia
https://www.hmpgloballearningnetwork.com/site/jcp/news/capivasertib-plus-palbociclib-and-fulvestrant-demonstrated-safety-tolerability-among
Capivasertib Plus Palbociclib and Fulvestrant Demonstrated Safety, Tolerability Among Patients With...
capivasertibpluspalbociclibfulvestrant
https://www.breastcancer.org/podcast/capivasertib
Experimental Capivasertib Seems Promising for Advanced-Stage, Hormone Receptor-Positive,...
Dr. Nicholas Turner explains research looking at capivasertib, a new targeted therapy medicine.
for advancedhormone receptorexperimentalcapivasertibseems
https://www.aacr.org/about-the-aacr/newsroom/news-releases/adding-capivasertib-to-fulvestrant-improves-progression-free-survival-in-patients-with-advanced-hormone-receptor-positive-breast-cancer/
Adding Capivasertib to Fulvestrant Improves Progression-free Survival in Patients With Advanced...
Adding Capivasertib to Fulvestrant Improves Progression-free Survival in Patients With Advanced Hormone Receptor-positive Breast Cancer
progression free survival
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-capivasertib-advanced-breast-cancer-resistant-hormone-therapy-faktion
A trial of capivasertib for advanced breast cancer that has become resistant to hormone therapy...
This trial looked at capivasertib (AZD5363) with a hormone therapy drug called fulvestrant.
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00546&r=1
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients with...
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients with Progressive Meningiomas
fak inhibitorvismodegibcapivasertib